Get started
Author

Rikako Tabata

Observed name: R ikako Tabata
ORCID: 0009-0008-3839-5323
Observed ORCID: 0009-0008-3839-5323
OpenAlex ID: A5133311834
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling
2022 · Yoshiaki Abe, Mamiko Sakata-Yanagimoto, et al. · Nature Cell Biology · 103
PDF
Emerging Immunotherapy for Acute Myeloid Leukemia
2021 · Rikako Tabata, SungGi Chi, et al. · International Journal of Molecular Sciences · 77
PDF
Safety and efficacy of daratumumab in patients with multiple myeloma and severe renal failure
2021 · Ayumi Kuzume, Rikako Tabata, et al. · British Journal of Haematology · 28
Soluble B-cell maturation antigen levels for disease monitoring in oligosecretory and nonsecretory relapsed multiple myeloma
2024 · Daisuke Ikeda, Shuichi Aikawa, et al. · Blood · 20
Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma
2021 · Toshiki Terao, Youichi Machida, et al. · European Radiology · 20
Antibody response to COVID-19 vaccination in patients with lymphoma
2022 · Kentaro Narita, So Nakaji, et al. · International Journal of Hematology · 19
PDF
Antibody response to COVID-19 vaccine in 130 recipients of hematopoietic stem cell transplantation
2022 · Takafumi Tsushima, Toshiki Terao, et al. · International Journal of Hematology · 18
PDF
Carfilzomib-induced thrombotic microangiopathy is underestimated in clinical practice: A report of five patients and literature review
2022 · Toshiki Terao, Takafumi Tsushima, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 16
Prognostic Impact of Metabolic Heterogeneity in Patients With Newly Diagnosed Multiple Myeloma Using 18F-FDG PET/CT
2021 · Toshiki Terao, Youichi Machida, et al. · Clinical Nuclear Medicine · 16
Low clinical protective response to SARS-CoV-2 mRNA COVID-19 vaccine in patients with multiple myeloma
2022 · Toshiki Terao, Takeshi Yamashita, et al. · International Journal of Hematology · 14
PDF
Depletion of CD38 ‐positive regulatory T cells by anti‐CD38 monoclonal antibodies induces a durable response to SARS‐CoV ‐2 vaccination in patients with plasma cell dyscrasia
2022 · Toshiki Terao, Takashi Naduka, et al. · British Journal of Haematology · 14
Letermovir Administration to Prevent Cytomegalovirus Reactivation Is the Potential Risk of Chronic Graft-Versus-Host Disease in Patients Who Received Haploidentical Stem-Cell Transplantation With Post-Transplant Cyclophosphamide
2021 · Toshiki Terao, Ken-ichi Matsuoka, et al. · Frontiers in Oncology · 13
PDF
Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease
2023 · Daisuke Ikeda, Ami Fukumoto, et al. · Blood Cancer Journal · 12
PDF
Distinct follicular T cell subsets regulate lymphoma progression and outcomes
2025 · Yoshiaki Abe, Junko Zenkoh, et al. · Cancer Cell · 11
Antibody status following booster vaccination against SARS‐CoV ‐2 virus in patients with haematologic malignancies
2022 · Daisuke Ikeda, Toshiki Terao, et al. · British Journal of Haematology · 9
Management of lymphoma-associated chylothorax by interventional radiology and chemotherapy: a report of five cases
2022 · Ami Fukumoto, Toshiki Terao, et al. · International Journal of Hematology · 8
Cytomegalovirus reactivation in patients with multiple myeloma administered daratumumab-combination regimens
2021 · Rikako Tabata, Nobue Sato, et al. · Annals of Hematology · 8
Real-world applicability of the International Metabolic Prognostic Index in DLBCL: a validation cohort study
2024 · Daisuke Ikeda, Mitsuaki Oura, et al. · Blood Advances · 6
PDF
Analysis of baseline circulating tumor cells integrated with PET/CT findings in transplant-ineligible multiple myeloma
2023 · Daisuke Ikeda, Toshiki Terao, et al. · Blood Advances · 6
PDF
Impaired Antibody Response Following the Second Dose of the BNT162b2 Vaccine in Patients With Myeloproliferative Neoplasms Receiving Ruxolitinib
2022 · Daisuke Ikeda, Toshiki Terao, et al. · Frontiers in Medicine · 6
PDF
Association of loss of spleen visualization on whole-body diffusion-weighted imaging with prognosis and tumor burden in patients with multiple myeloma
2021 · Toshiki Terao, Youichi Machida, et al. · Scientific Reports · 6
PDF
Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies
2024 · Daisuke Ikeda, Tatsuya Isezaki, et al. · Cancer Chemotherapy and Pharmacology · 5
PDF
Clinical Characteristics and Outcomes of Cyclin D1–Positive AL Amyloidosis
2023 · Takafumi Tsushima, Toshiki Terao, et al. · American Journal of Clinical Pathology · 5
PDF
Limited efficacy of high-dose methotrexate to prevent the central nervous system relapse in patients with IVLBCL
2022 · Toshiki Terao, Takafumi Tsushima, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 5
Soluble BCMA as a biomarker reflecting tumor volume and treatment response in Waldenström macroglobulinemia
2025 · Mitsuaki Oura, Daisuke Ikeda, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 4
Works count: 74
Citation count: 486
H-index: 12
I10-index: 14
Year
Topic
Type